期刊文献+

冬病夏治治疗慢性阻塞性肺疾病300例临床观察 被引量:17

Therapeutic Effect of Methods of Treating Winter-season Diseases in Summer on Chronic Obstructive Pulmonary Disease:A Report of 300 Cases
原文传递
导出
摘要 目的:观察冬病夏治穴位贴敷疗法治疗慢性阻塞性肺疾病(COPD)的临床疗效。方法:对300例符合诊断标准的COPD患者分别于夏季"三伏"第1天给予穴位贴敷。结果:总有效率为87.33%,控显率为70.67%。治疗前后住院天数、发作次数、第1秒用力呼气量占预计值的百分比(FEV_1)、第1秒用力呼气量与用力呼气量之比(FEV_1/FVC)比较,差异均有显著性意义(P<0.05)。结论:冬病夏治穴位贴敷疗法治疗慢性阻塞性肺疾病可获得一定的疗效。 Objective: To observe the clinical effect of methods of treating winter-season diseases in summer on chronic obstructive pulmonary disease (COPD). Methods: Three-hundreds patients with COPD were treated with point application therapy on the first day of the three ten-day periods of the hot season, and curative effect was evaluated 3 months after treatment. Results: After treatment, the total effective rate was 87.33%, and the controlled and remarkable effective rate was 70.67%. The differences of hospitalization days, attack frequency, forced expiratory volume in the one second(FEV1), FEV# forced vital capacity(FVC) ratio were significant before and after treatment (P 〈 0.05). Conclusion: Point application therapy based on the theory of treating winter-season diseases in summer exerts certain curative effect in treating COPD.
出处 《新中医》 CAS 北大核心 2011年第2期116-118,共3页 New Chinese Medicine
基金 国家科技支撑计划资助项目(编号:2008BAI53B061)
关键词 慢性阻塞性肺疾病 冬病夏治 穴位贴敷 Chronic Obstructive Pulmonary Disease Treating Winter-season Diseases in Summer Point Application Therapy
  • 相关文献

参考文献4

二级参考文献16

  • 1周志华,吴洲红,周丽萍,吴伯庠.三伏膏穴位贴敷治疗慢性支气管炎临床研究[J].针灸临床杂志,2004,20(8):44-45. 被引量:13
  • 2米建平,刘炳权,符文彬,樊莉,李勇,蒙昌荣,李伟雄,朱晓平,文幸.天灸疗法防治支气管哮喘181例疗效观察[J].新中医,2005,37(2):61-62. 被引量:42
  • 3有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 4中华人民共和国卫生部.中药新药治疗慢性支气管炎的临床研究指导原则[S].中药新药临床指导原则,1993:1-5.
  • 5Churg A, Dai J,Tai H, et al. Tumor necrosis factor-alpha was central to acute cigarette smoke-induced inflammation and connective tissue breakdown[J]. Am Jrespir Crit Care Med,2002,166(6) : 849 - 854.
  • 6Vemooy Jll, Kucukaycan M, Jacobs JA, et al. Local nad systemic inlfammationin patients with chronic obstructive pulmonary disease : soluble tumor necrosis factor receptors are increased in sputum. Am J RespirCa-itCare Med ,2002,166 : 1218 - 1224.
  • 7冉丕鑫 王辰 姚婉贞 等.我国部分地区慢性阻塞性肺疾病流行病学研究[J].中华结核和呼吸杂志,2007,.
  • 8GOLD Executive Committee[DB/OL]. Guidelines: Global Strategy for Diagnosis, Management, and Prevention of COPD,November 2006 [ 2006-11-18 ]. http://www.goldcopd.com/Guidelineitem. asp? 11 =2&12 = 1&intId =989.
  • 9Celli BR, MacNee W, Committee members. Standard for the diagnosis and treatment of patients with COPD : a summary of the ATS/ERS position paper. Eur Respir J, 2004,23:932-946.
  • 10Celli BR, Cote CG, Matin JM, et al. The body mass index,airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med, 2004,350 : 1005-1012.

共引文献1903

同被引文献246

引证文献17

二级引证文献119

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部